Generative AI In Medicine Market Report 2026

Generative AI In Medicine Market Overview

• Generative AI In Medicine market size has reached to $0.95 billion in 2025 • Expected to grow to $5.77 billion in 2030 at a compound annual growth rate (CAGR) of 43.4% • Growth Driver: Surge In Digital Health Records Fuels Growth In generative AI For Medicine • Market Trend: Revolutionizing Healthcare DiagnaMed's CERVAI Launches Advanced AI Solutions For Brain Health • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Generative AI In Medicine Market?

Generative artificial intelligence (AI) in medicine refers to using AI systems to generate new data, models, or insights to advance healthcare and medical research. It aims to improve diagnosis, treatment, and overall patient care by leveraging data-driven insights and innovative solutions. The main components of generative artificial intelligence (AI) in medicine include solutions and services. Solutions in the generative Solutions in the generative AI in medicine market refer to the various advanced technologies and tools designed to improve healthcare delivery and outcomes. These solutions encompass a wide range of applications, including AI-driven diagnostic tools, virtual nursing assistants, and platforms for medical imaging analysis. The various functions include virtual nursing assistants, robot-assisted AI surgery, administrative process optimization, and medical imaging analysis. The several applications involved are medical imaging, drug discovery, medical diagnosis, patient data analysis, and others, and are used by multiple end-users such as hospitals and clinics, clinical research organizations, healthcare organizations, diagnostic centers, and others.

What Is The Generative AI In Medicine Market Growth Forecast?

The generative AI in medicine market size is expected to see exponential growth in the next few years. It will grow to $5.77 billion in 2030 at a compound annual growth rate (CAGR) of 43.4%. The growth in the forecast period can be attributed to expansion of AI-assisted drug discovery solutions, integration of generative AI in treatment planning, increased use of virtual nursing assistants, adoption of robot-assisted AI surgery, growth in predictive patient data analytics. Major trends in the forecast period include AI-driven diagnostic tools, personalized treatment planning, virtual nursing assistants, robot-assisted AI surgery, patient data analysis and predictive healthcare.

Global Generative AI In Medicine Market Segmentation

1) By Component: Solutions, Service 2) By Function: Virtual Nursing Assistants, Robot-Assisted AI Surgery, Administrative Process Optimization, Medical Imaging Analysis 3) By Application: Medical Imaging, Drug Discovery, Medical Diagnosis, Patient Data Analysis, Other Applications 4) By End-User: Hospitals And Clinics, Clinical Research, Healthcare Organizations, Diagnostic Centers, Other End-Users Subsegments: 1) By Solutions: Diagnostic Tools, Treatment Planning Systems, Personalized Medicine Platforms, Drug Discovery And Development Solutions, Medical Imaging And Analysis Software, Electronic Health Record (EHR) Enhancement Tools 2) By Services: Consulting Services, Implementation And Integration Services, Training And Education Services, Technical Support And Maintenance, Research And Development Services.

What Is The Driver Of The Generative AI In Medicine Market?

The surge in digital health records is expected to propel the growth of generative artificial intelligence (AI) in medicine market going forward. Digital health records, or electronic health records (EHRs), are systematic collections of patient health information stored electronically, enabling sharing across healthcare settings and improving the efficiency and quality of patient care. The surge in digital health records is driven by improved patient care, increased efficiency in healthcare delivery, regulatory support and incentives, advancements in technology, and enhanced patient engagement and empowerment. Artificial intelligence (AI) in medicine enhances digital health records by automating documentation, structuring data, providing predictive insights, and generating personalized summaries to improve accuracy, accessibility, and overall patient care. For instance, in July 2024, according to the European Commission, a Belgium-based executive branch of the European Union, the access to electronic health records score increased to 79% in 2024 from 72% in 2023. Therefore, the surge in digital health records is driving generative artificial intelligence (AI) in medicine market.

Key Players In The Global Generative AI In Medicine Market

Major companies operating in the generative AI in medicine market are Microsoft Corporation, Intel Corporation, International Business Machines Corporation, NVIDIA Corporation, Philips Healthcare, Veeva Systems Inc., Nuance Communications Inc., Babylon Health Ltd., Tempus Labs Inc., DeepMind Technologies Limited, Owkin Inc., Viz.AI Inc., Recursion Pharmaceuticals Inc., Caresyntax Inc., Relay Therapeutics Inc., Exscientia plc, Paige AI Inc., BenevolentAI Limited, Atomwise Inc., Healx Ltd., Zebra Medical Vision Ltd., Eyenuk Inc., Syntegra Ltd., Arterys Inc.

Global Generative AI In Medicine Market Trends and Insights

Major companies operating in the generative artificial intelligence (AI) in medicine market are focused on developing innovative technologies, such as AI solutions for brain health and wellness, to advance cognitive assessment, improve patient care, and enhance overall mental health management. AI solutions for brain health and wellness are advanced artificial intelligence technologies designed to assess, monitor, and improve cognitive function and mental well-being. For instance, in February 2024, DiagnaMed Holdings Corp., a Canada-based company focused on developing AI-powered digital therapeutics, launched CERVAI, the first AI solution for human mental health and wellness. This innovative solution leverages advanced artificial intelligence to evaluate cognitive function and brain wellness comprehensively. Its key features include cutting-edge algorithms that analyze diverse data inputs, including cognitive tests and brain imaging, to provide accurate insights into mental health conditions. The tool offers personalized assessments and actionable recommendations, enabling early detection of cognitive issues and tailored interventions.

What Are Latest Mergers And Acquisitions In The Generative AI In Medicine Market?

In December 2024, General Inception, a US-based biotech company igniter, acquired Enable Medicine for an undisclosed amount. With this acquisition, General Inception aims to enhance its generative AI and biological data capabilities by integrating Enable Medicine’s platform, which uses generative AI to search disease-related cellular atlases and unlock novel therapeutic insights. Enable Medicine is a US-based software company specializing in AI-led generative biological search for drug discovery.

Regional Insights

North America was the largest region in the generative artificial intelligence (AI) in medicine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Generative AI In Medicine Market?

The generative artificial intelligence (AI) in medicine market consists of revenues earned by entities providing services such as drug discovery and development, clinical trials, diagnostics, and virtual health assistants. The market value includes the value of related goods sold by the service provider or included within the service offering. The generative artificial intelligence (AI) in medicine market also includes medical imaging analysis tools, drug discovery platforms, clinical decision support systems, patient data synthesis solutions, administrative automation software, and precision medicine applications. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Generative AI In Medicine Market Report 2026?

The generative ai in medicine market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the generative ai in medicine industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.